The Biotech Stocks JMP Is Watching – Merck & Company, Inc …

Related MRKSunTrust’s Latest Comments On MerckMorgan Stanley’s Major Pharma Q1 PreviewMerck, NewLink Ebola Vaccine Enters Third Phase III Study – Analyst Blog(Zacks)Related Why Johnson & Johnson’s Strong Pharmaceutical Business Is A ConcernBenzinga’s Top UpgradesNew drug trial results positive(Investor’s Business Daily)In a report published Thursday, JMP Securities analysts expressed their views on Biotechnology stocks after the EASL abstracts were made available […]

Top Alternative Investments To The Stock Market – Investopedia

Discussions about investing are seldom complete without the mention of stock markets—the gains, risks, and opportunities. Sure, stocks and linked products like mutual funds are a part of many investor portfolios, but not all. Many investors are wary of the stock markets for a number of reasons and are thus looking at other investment options. There are a wide variety […]

It's stunning how little interest mom and pop have in the stock market

More Charts

“Over the past 10 years, S&P 500 constituents have bought back nearly $4 trillion of stock while investors have added cumulative inflows of less than $100 billion to US equities via mutual funds and exchange traded funds,” Citi’s Tobias Levkovich said in a note to clients today.This is not news. But it continues to be a jarring reminder of […]

Americans Avoid Investing In Stock Market – Money Pulse | Bankrate …

PrintSubscribeinvestingDid you miss the stock market rally? You’re not aloneBy Claes Bell, CFA • Bankrate.comIt’s often said that a rising tide lifts all boats, but a rising tide isn’t much help if you don’t have a boat. In the midst of a six-year market rally, more than half of Americans don’t own any stock investments at all, potentially missing out […]

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept …

Major updates in the biotech sector over the past four trading days were on the pipeline and regulatory front from companies like Alkermes (ALKS – Analyst Report) and Amgen (AMGN – Analyst Report) among others.Recap of the Week’s Most Important Stories1. Alkermes’ experimental schizophrenia treatment, ALKS 3831, fared well in a mid-stage study. Earlier this year, the company had said […]

5 Biotech Stocks Roth Capital Analysts Are Watching – Celldex …

Related CLDXWhy Cowen & Co Likes Celldex Therapeutics Following Its FDA ‘Breakthrough’Biotech Stocks Moving HigherCelldex Therapeutics(Investor’s Business Daily)Related BLRXMorning Market GainersBenzinga’s Top #PreMarket GainersRoth Capital Weighs In On 5 Biotech Stocks To Watch(Seeking Alpha)As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.”Though […]

5 Reasons Not To Invest In Energy

There are a lot of options for your hard earned capital and no shortage of folks wanting to tell you how to use it.Recent trends have been very profitable in different sectors. On the other hand, energy has displayed a horrendous previous 52 weeks.So here are 5 reasons not to invest in energy.Biotech is hot right now, having risen 30% […]